跳至主要内容
临床试验/NL-OMON34621
NL-OMON34621
尚未招募
不适用

Drug eluting balloon for in-stent restenosis. Multi-center, randomized trial to study the effect of the SeQuent Please drug-eluting balloon versus the Xience Prime drug-eluting stent for the treatment of in-stent restenosis - Drug eluting balloon for in-stent restenosis

Academisch Medisch Centrum0 个研究点目标入组 270 人待定

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
10011082
发起方
Academisch Medisch Centrum
入组人数
270
状态
尚未招募
最后更新
去年

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
去年
研究类型
Interventional

研究者

入排标准

入选标准

  • Restenosis of initially stented coronary artery
  • Restenosis of any type of stent; all drug\-eluting stents or bare metal stents
  • Restenosis must be present \> 50% in\-stent and \< 5 mm out of the stent
  • Amendable to PCI treatment with either the SeQuent Please DEB or the Xience Prime DES

排除标准

  • The impossibility to arrange a follow\-up coronary angiography at 6 months (± 1 month) after baseline procedure
  • Life expectancy less than one year
  • In\-stent re\-restenosis already treated with a second stent
  • Requirement for PCI in the same vessel or expected in the next 6 months

结局指标

主要结局

未指定

相似试验